InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Rivard Paul, Directeur Exécutif. Officer active across 1 company, notably MyMD Pharmaceuticals, Inc.. In total, 4 disclosures have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €275k. Activity tracked since 23 November 2021. The latest transaction was disclosed on 24 August 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Paul Rivard is Executive Vice President of Operations and General Counsel at MyMD Pharmaceuticals, Inc. He oversees the operations and legal matters of the company, bringing his expertise in management and law.